Aaron S. Goetz

3.9k total citations · 1 hit paper
26 papers, 1.8k citations indexed

About

Aaron S. Goetz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems. According to data from OpenAlex, Aaron S. Goetz has authored 26 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in Aaron S. Goetz's work include Receptor Mechanisms and Signaling (15 papers), Regulation of Appetite and Obesity (6 papers) and Neuropeptides and Animal Physiology (6 papers). Aaron S. Goetz is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Regulation of Appetite and Obesity (6 papers) and Neuropeptides and Animal Physiology (6 papers). Aaron S. Goetz collaborates with scholars based in United States, United Kingdom and Netherlands. Aaron S. Goetz's co-authors include Thomas J. Rimele, David L. Saussy, Timothy A. True, Stuart D.C. Ward, Andrew J. Peat, Diane M. Ignar, Celia P. Briscoe, David F. Corbett, Charity Atkins and Jeffrey M. Axten and has published in prestigious journals such as Biochemistry, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Aaron S. Goetz

26 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity

2013 364 citations Charity Atkins, Qi Liu et al. Cancer Research profile →

Peers

Countries citing papers authored by Aaron S. Goetz

Since Specialization

Citations

This map shows the geographic impact of Aaron S. Goetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron S. Goetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron S. Goetz more than expected).

Fields of papers citing papers by Aaron S. Goetz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron S. Goetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron S. Goetz. The network helps show where Aaron S. Goetz may publish in the future.

Co-authorship network of co-authors of Aaron S. Goetz

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron S. Goetz. A scholar is included among the top collaborators of Aaron S. Goetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron S. Goetz. Aaron S. Goetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity breakdown → 2013 ·Cancer Research ·Charity Atkins, Qi Liu, Elisabeth A. Minthorn, ShuYun Zhang, David J. Figueroa, Katherine G. Moss, Thomas B. Stanley, Brent Sanders, Aaron S. Goetz, (unknown), Anthony E. Choudhry, Hasan Alsaid, Beat M. Jucker, Jeffrey M. Axten, Rakesh Kumar	364
2	Regulation of Ingestive Behaviors in the Rat by GSK1521498, a Novel μ-Opioid Receptor-Selective Inverse Agonist 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Diane M. Ignar, Aaron S. Goetz, (unknown), (unknown), (unknown), (unknown), Joyce A. Boucheron, (unknown), (unknown), Andrea H. Epperly, Todd Shearer, Scott D. Sorensen, Jason D. Speake, Jonathan D. Hommel	41
3	Tetrahydroquinoline derivatives as opioid receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Cunyu Zhang, Susan M. Westaway, Jason D. Speake, Michael J. Bishop, Aaron S. Goetz, (unknown), (unknown), Andrea H. Epperly	7
4	Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Alejandro J. Daniels, David N. Deaton, Aaron S. Goetz, Christopher P. Laudeman, (unknown), David L. Musso, (unknown), Jerzy R. Szewczyk, Cunyu Zhang	10
5	Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Tara Rheault, Thomas R. Caferro, Scott H. Dickerson, (unknown), Michael D. Gaul, Aaron S. Goetz, Robert J. Mullin, Octerloney B. McDonald, Kimberly G. Petrov, David W. Rusnak, Lisa M. Shewchuk, Glenn Spehar, Anne T. Truesdale, Dana E. Vanderwall, Edgar R. Wood, David Uehling	72
6	Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptor 2007 ·Bioorganic & Medicinal Chemistry Letters ·Stephen C. McKeown, David F. Corbett, Aaron S. Goetz, (unknown), Eric C. Bigham, Celia P. Briscoe, Andrew J. Peat, Steve P. Watson, Deirdre M. B. Hickey	56
7	Synthesis and activity of small molecule GPR40 agonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Dulce Garrido, David F. Corbett, (unknown), Aaron S. Goetz, (unknown), (unknown), Wendy Y. Mills, Terrence L. Smalley, Celia P. Briscoe, Andrew J. Peat	87
8	Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules 2006 ·British Journal of Pharmacology ·Celia P. Briscoe, Andrew J. Peat, Stephen C. McKeown, David F. Corbett, Aaron S. Goetz, (unknown), (unknown), Terry Kenakin, John L. Andrews, Carina Ämmälä, James A. Fornwald, Diane M. Ignar, Stephen Jenkinson	343
9	The discovery and optimization of pyrimidinone-containing MCH R1 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Donald L. Hertzog, Kamal Albarazanji, Eric C. Bigham, Michael J. Bishop, (unknown), (unknown), Joel P. Cooper, (unknown), Dulce Garrido, Aaron S. Goetz, Mary K. Grizzle, Yu Guo, Anthony L. Handlon, Diane M. Ignar, (unknown), Andrew J. Peat, Francis X. Tavares, Huiqiang Zhou	39
10	Novel benzimidazole-based MCH R1 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Andrew J. Carpenter, Kamal Albarazanji, (unknown), Michael J. Bishop, (unknown), Joel P. Cooper, Aaron S. Goetz, Mary K. Grizzle, Donald L. Hertzog, Diane M. Ignar, (unknown), (unknown), Jason D. Speake, (unknown)	21
11	6-(4-Chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-Based Melanin-Concentrating Hormone Receptor 1 Antagonist 2006 ·Journal of Medicinal Chemistry ·Francis X. Tavares, Kamal Albarazanji, Michael J. Bishop, (unknown), (unknown), Joel P. Cooper, Paul L. Feldman, Dulce Garrido, Aaron S. Goetz, Mary K. Grizzle, Donald L. Hertzog, Diane M. Ignar, Daniel G. Lang, Maggie S. McIntyre, Ronda J. Ott, Andrew J. Peat, Huiqiang Zhou	17
12	Development of a Facile Method for High Throughput Screening with Reporter Gene Assays 2000 ·SLAS DISCOVERY ·Aaron S. Goetz, John L. Andrews, (unknown), Diane M. Ignar	19
13	A combination assay for simultaneous assessment of multiple signaling pathways 1999 ·Journal of Pharmacological and Toxicological Methods ·Aaron S. Goetz, James A. Liacos, (unknown), Diane M. Ignar	9
14	Development of scintillation-proximity assays for alpha adrenoceptors 1999 ·Journal of Pharmacological and Toxicological Methods ·(unknown), David L. Saussy, Aaron S. Goetz	21
15	α₁-Adrenergic Receptor Subtype Determinants for 4-Piperidyl Oxazole Antagonists 1998 ·Biochemistry ·Nobuko Hamaguchi, Timothy A. True, Aaron S. Goetz, (unknown), Terry P. Lybrand, Peter W. Jeffs	16
16	Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·D L Saussy, Aaron S. Goetz, Kennedy L. Queen, (unknown), Michael W. Lutz, Thomas J. Rimele	71
17	BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors 1995 ·European Journal of Pharmacology ·Aaron S. Goetz, (unknown), Stuart D.C. Ward, Timothy A. True, Thomas J. Rimele, David L. Saussy	285
18	The α_1C‐adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types 1995 ·British Journal of Pharmacology ·Julie Tseng-Crank, Thomas A. Kost, Aaron S. Goetz, (unknown), (unknown), (unknown), N Godinot, Cary N. Robertson, D L Saussy	44
19	Characterization of alpha-1 adrenoceptor subtypes in human and canine prostate membranes. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·Aaron S. Goetz, Michael W. Lutz, Thomas J. Rimele, D L Saussy	45
20	[ON ALTERATION OF VASOMOTOR ACTION BY CA++ AND K+ IONS. A CONTRIBUTION TO THE TONE PROBLEM]. 1964 ·PubMed ·K. Brecht, (unknown), Aaron S. Goetz	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact